Literature DB >> 15593049

The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.

Ulf Janssen1, Athina Vassiliadou, Stephen G Riley, Aled O Phillips, Jürgen Floege.   

Abstract

The Goto Kakakizaki (GK) rat is a moderately diabetic rat strain that was developed by repeated inbreeding of glucose-intolerant Wistar rats over several generations. In contrast to many other rodent models of non-insulin-dependent diabetes, GK rats do not exhibit hyperlipidemia or obesity. Hyperglycemia in the GK rat is associated with the development of age-dependent renal structural changes that are similar to those described in patients with prolonged non-insulin-dependent diabetes mellitus who have not developed overt renal disease. Hyperglycemia in the GK rat is, however, not associated with overt proteinuria or progressive nephropathy. In the present review the metabolic characteristics as well as renal and nonrenal changes observed in GK rats are described. Moreover the effects on renal function and morphology of secondary injurious stimuli, such as mesangioproliferative glomerulonephritis and hypertension, superimposed on type II diabetes in GK rats are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15593049

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  15 in total

1.  Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Nicola Aberdein; Xinchun Zhou; Jan M Williams; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2017-03-27       Impact factor: 10.190

Review 2.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

3.  Comparison of the Development Diabetic Induced Renal Disease in Strains of Goto-Kakizaki Rats.

Authors:  Naoki Kojima; Tiffani N Slaughter; Adrienne Paige; Sota Kato; Richard J Roman; Jan M Williams
Journal:  J Diabetes Metab       Date:  2013-05-30

Review 4.  A review of rodent models of type 2 diabetic skeletal fragility.

Authors:  Roberto J Fajardo; Lamya Karim; Virginia I Calley; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

5.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

6.  Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

Authors:  Mostafa M Elgebaly; Aisha Kelly; Alex K Harris; Hazem Elewa; Vera Portik-Dobos; Pimonrat Ketsawatsomkron; Mario Marrero; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

7.  Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.

Authors:  Jin Hee Lee; Shichao Xia; Louis Ragolia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-07       Impact factor: 3.619

8.  Fasting hyperglycemia in the Goto-Kakizaki rat is dependent on corticosterone: a confounding variable in rodent models of type 2 diabetes.

Authors:  Sara A Beddow; Varman T Samuel
Journal:  Dis Model Mech       Date:  2012-08-03       Impact factor: 5.758

Review 9.  Advances in murine models of diabetic nephropathy.

Authors:  Li-Li Kong; Hao Wu; Wen-Peng Cui; Wen-Hua Zhou; Ping Luo; Jing Sun; Hang Yuan; Li-Ning Miao
Journal:  J Diabetes Res       Date:  2013-06-13       Impact factor: 4.011

10.  A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats.

Authors:  Weili Shen; Jiejie Hao; Chuan Tian; Jinmin Ren; Lu Yang; Xuesen Li; Cheng Luo; Carl W Cotma; Jiankang Liu
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.